VH032-thiol-C6-NH2 is an advanced E3 Ligase Ligand-Linker Conjugate designed for PROTAC (Proteolysis Targeting Chimera) drug development. This compound features the VH032 ligand, a well-characterized small molecule binder for the VHL (von Hippel-Lindau) E3 ligase, equipped with a thiol handle and a six-carbon (C6) alkyl linker terminating with an amine group. As a versatile building block, VH032-thiol-C6-NH2 enables researchers to efficiently conjugate target-binding ligands via the thiol or amine functional groups, facilitating the creation of custom PROTACs for targeted protein degradation. With its optimized linker design, this conjugate ensures effective spatial orientation and functional versatility, supporting the development of novel small-molecule degraders targeting disease-relevant proteins. VH032-thiol-C6-NH2 is ideal for medicinal chemistry, chemical biology, and early-stage drug discovery workflows that focus on advancing the field of targeted protein degradation and PROTAC therapeutics.
Structure of 2098836-63-4
* For research and manufacturing use only. Not for human or clinical use.
| Size | Price | Stock | Quantity |
|---|---|---|---|
| -- | $-- | In stock |
Looking for different specifications? Click to request a custom quote!
Capabilities & Facilities
Popular Publications Citing BOC Sciences Products
Background Introduction
VH032-thiol-C6-NH2 is a specially designed E3 ligase ligand-linker conjugate widely used in the development of PROTACs (Proteolysis Targeting Chimeras). Featuring a VH032 moiety (a highly validated ligand for the Von Hippel-Lindau [VHL] E3 ligase) tethered via a flexible hexyl (C6) linker and terminating in a thiol and amine group, this compound enables precise and versatile conjugation chemistry. Its unique functional groups provide essential reactive handles for further PROTAC assembly, supporting the efficient targeting and removal of disease-relevant proteins.
Mechanism
VH032-thiol-C6-NH2 operates as a modular building block in PROTAC synthesis. The VH032 unit non-covalently binds to the substrate recognition domain of the VHL E3 ubiquitin ligase complex. The hexyl (C6) linker offers spatial flexibility, while the terminal thiol and amine functionalities allow for selective coupling to various warheads or target-binding ligands via amide or thioether linkages. Upon successful conjugation, the resulting PROTAC molecule mediates target protein ubiquitination by recruiting the E3 ligase into close proximity with the protein of interest, marking it for subsequent proteasomal degradation.
Applications
VH032-thiol-C6-NH2 is extensively utilized in targeted protein degradation research and PROTAC platform development. Its customizable linker system facilitates the rapid synthesis of diverse PROTACs for high-throughput screening, medicinal chemistry optimization, and in vitro/in vivo functional studies. Typical applications include designing PROTAC tool compounds for oncology, neurodegenerative diseases, immunology, and other therapeutic indications where protein degradation offers a unique intervention strategy. Additionally, its reactive handles support site-specific conjugation and enable seamless integration into bifunctional chimeric molecules for drug discovery and development.
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
Please contact us with any specific requirements and we will get back to you as soon as possible.